Stent Thrombosis

被引：332

作者：

Holmes, David R., Jr. ^{[1
]}

Kereiakes, Dean J. ^{[2
]}

Garg, Scot ^{[4
]}

Serruys, Patrick W. ^{[4
]}

Dehmer, Gregory J. ^{[5
]}

Ellis, Stephen G. ^{[3
]}

Williams, David O. ^{[6
]}

Kimura, Takeshi ^{[7
]}

Moliterno, David J. ^{[8
]}

机构：

[1] Mayo Clin, Div Cardiovasc Dis Internal Med, Rochester, MN 55905 USA

[2] Christ Hosp, Heart & Vasc Ctr, Cincinnati, OH 45219 USA

[3] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA

[4] Erasmus MC, Thoraxctr, Dept Intervent Cardiol, Rotterdam, Netherlands

[5] Scott & White Mem Hosp & Clin, Div Cardiol, Temple, TX USA

[6] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA

[7] Kyoto Univ Hosp, Dept Cardiovasc Med, Kyoto 606, Japan

[8] Univ Kentucky, Dept Med, Div Cardiol, Lexington, KY 40506 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 56卷 / 17期

关键词：

acute myocardial infarction; bare-metal stent; drugeluting stent; dual antiplatelet therapy; percutaneous coronary intervention; stent thrombosis; DRUG-ELUTING STENT; ELEVATION MYOCARDIAL-INFARCTION; DUAL ANTIPLATELET THERAPY; BARE-METAL STENTS; PERCUTANEOUS CORONARY INTERVENTION; ROUTINE CLINICAL-PRACTICE; LONG-TERM OUTCOMES; POOLED ANALYSIS; RESPONSE VARIABILITY; CLOPIDOGREL THERAPY;

D O I：

10.1016/j.jacc.2010.07.016

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Intense investigation continues on the pathobiology of stent thrombosis (ST) because of its morbidity and mortality. Because little advance has been made in outcomes following ST, ongoing research is focused on further understanding predictive factors as well as ST frequency and timing in various patient subsets, depending upon whether a drug-eluting stent or bare-metal stent has been implanted. Although the preventive role of antiplatelet therapies remains unchallenged, new data on genomics and variability in response to antiplatelet therapy, as well as the effects of novel therapeutic agents and duration of therapy, have become available. The goal remains identification of patients at particularly increased risk of ST so that optimal prevention strategies can be developed and employed. © 2010 American College of Cardiology Foundation.

引用

页码：1357 / 1365

页数：9

共 87 条

[1] Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment [J].

Airoldi, Flavio ;

Colombo, Antonio ;

Morici, Nuccia ;

Latib, Azeem ;

Cosgrave, John ;

Buellesfeld, Lutz ;

Bonizzoni, Erminio ;

Carlino, Mauro ;

Gerckens, Ulrich ;

Godino, Cosmo ;

Melzi, Gloria ;

Michev, Iassen ;

Montorfano, Matteo ;

Sangiorgi, Giuseppe Massimo ;

Qasim, Asif ;

Chieffo, Alaide ;

Briguori, Carlo ;

Grube, Eberhard .

CIRCULATION, 2007, 116 (07) :745-754

[2]

BHATT DL, 2009, TRANSC CARD THER SEP

[3] Use of Drug-Eluting Stents in Acute Myocardial Infarction A Systematic Review and Meta-Analysis [J].

Brar, Somjot S. ;

Leon, Martin B. ;

Stone, Gregg W. ;

Mehran, Roxana ;

Moses, Jeffrey W. ;

Brar, Simerjeet K. ;

Dangas, George .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (18) :1677-1689

[4]

Brodie BR, 2008, JACC-CARDIOVASC INTE, V1, P405, DOI 10.1016/j.jcin.2008.06.005

[5]

Byrne R A, 2009, Minerva Cardioangiol, V57, P567

[6] Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study [J].

Byrne, Robert A. ;

Schulz, Stefanie ;

Mehilli, Julinda ;

Ijima, Raisuke ;

Massberg, Steffen ;

Neumann, Franz-Josef ;

ten Berg, Jurrien M. ;

Schoemig, Albert ;

Kastrati, Adnan .

AMERICAN HEART JOURNAL, 2009, 157 (04) :620-624

[7] Impact of Target Lesion and Nontarget Lesion Cardiac Events on 5-Year Clinical Outcomes After Sirolimus-Eluting or Bare-Metal Stenting [J].

Chacko, Riya ;

Mulhearn, Meredith ;

Novack, Victor ;

Novack, Lena ;

Mauri, Laura ;

Cohen, Sidney A. ;

Moses, Jeffrey ;

Leon, Martin B. ;

Cutlip, Donald E. .

JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (06) :498-503

[8] Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention [J].

Chen, Kang-Yin ;

Rha, Seung-Woon ;

Li, Yong-Jian ;

Poddar, Kanhaiya L. ;

Jin, Zhe ;

Minami, Yoshiyasu ;

Wang, Lin ;

Kim, Eung Ju ;

Park, Chang Gyu ;

Seo, Hong Seog ;

Oh, Dong Joo ;

Jeong, Myung Ho ;

Ahn, Young Keun ;

Hong, Taek Jong ;

Kim, Young Jo ;

Hur, Seung Ho ;

Seong, In Whan ;

Chae, Jei Keon ;

Cho, Myeong Chan ;

Bae, Jang Ho ;

Choi, Dong Hoon ;

Jang, Yang Soo ;

Chae, In Ho ;

Kim, Chong Jin ;

Yoon, Jung Han ;

Chung, Wook Sung ;

Seung, Ki Bae ;

Park, Seung Jung .

CIRCULATION, 2009, 119 (25) :3207-3214

[9] Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation [J].

Cook, Stephane ;

Wenaweser, Peter ;

Togni, Mario ;

Billinger, Michael ;

Morger, Cyrill ;

Seiler, Christian ;

Vogel, Rolf ;

Hess, Otto ;

Meier, Bernhard ;

Windecker, Stephan .

CIRCULATION, 2007, 115 (18) :2426-2434

[10] Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis [J].

Cook, Stephane ;

Ladich, Elena ;

Nakazawa, Gaku ;

Eshtehardi, Parham ;

Neidhart, Michel ;

Vogel, Rolf ;

Togni, Mario ;

Wenaweser, Peter ;

Billinger, Michael ;

Seiler, Christian ;

Gay, Steffen ;

Meier, Bernhard ;

Pichler, Werner J. ;

Jueni, Peter ;

Virmani, Renu ;

Windecker, Stephan .

CIRCULATION, 2009, 120 (05) :391-399

← 1 2 3 4 5 6 7 8 9 →